Additionally, dendritic cell-biomimetic nanoparticles and dendritic cell-mimicking nanovaccines (nanoDCs), fabricated from mature bone marrow-derived DC membranes loaded with TAAs improve CD8+ T cell priming, reduce tumor size, and inhibit metastasis (66, 67). This evidence concerns the gene CD8A and neoplasm.